Turnaround

While numerous biotechnology firms are scaling back expectations, Supernus Pharmaceuticals is projecting a surprisingly confident stance by reaffirming its annual...

Market experts are growing increasingly optimistic about defense technology specialist Mercury Systems, with Wall Street sentiment shifting decisively in the...

Biotechnology firm Equillium is executing a profound strategic overhaul, pivoting its entire operational focus to a single, promising drug candidate....

For Replimune and its investors, 2026 is shaping up to be a defining period. After a significant regulatory setback in...

The once high-flying restaurant chain Chipotle Mexican Grill is confronting significant headwinds. Following a disappointing earnings report and a reduction...

The athletic apparel landscape is undergoing a significant transformation, with former industry kingpin Nike facing substantial headwinds. As emerging competitors...

Kraft Heinz finds itself navigating turbulent waters as market confidence erodes following disappointing financial results and a downward revision of...

The Chinese electric vehicle giant BYD is navigating its most significant profit decline in four years, prompting a strategic pivot...

A dramatic shift in sentiment is underway among market experts covering Austrian steel producer Voestalpine. In a rapid succession of...

While Redcare Pharmacy shares continue their prolonged decline, having shed more than 60% from their December peak, a significant development...